ArticleCancers2022

Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma.

Lucia Minoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.